Nav: Home

An antibody-mimicking small molecule protects mice against lethal influenza

March 07, 2019

Researchers present a newly identified small molecule influenza inhibitor, which, when administered orally, is capable of protecting mice from extremely lethal doses of influenza. It achieves this effect by mimicking broadly neutralizing antibodies, the authors say. The study's results provide a proof-of-concept for antibody-guided, small molecule discovery and pave the way for a new class of "antibody mimetic" drugs, which could one day be used to neutralize a variety of viral infections. Each year, influenza epidemics cause millions of cases of severe illness and nearly 500,000 deaths worldwide. However, currently available seasonal vaccines offer limited protection against the various subtypes of the virus. The discovery of human broadly neutralizing antibodies (bnAbs) that neutralize the virus by targeting its hemagglutinin (HA) stem have opened the door for the development of broad spectrum ("universal") influenza vaccines. Unlike antibodies, however, small molecule drugs are well-suited for oral delivery and could be a desirable alternative to bnAbs, the authors say. Based on the structural knowledge of the interactions and molecular mechanism of anti-stem bnAb CR6261, Maria van Dongen and colleagues engineered a small molecule compound capable of neutralizing a wide range of influenza viruses. Van Dongen et al. screened nearly 500,000 small molecule compounds using the AlphaLISA (Amplified Luminescent Proximity Homogeneous Assay) technology to discover those that selectively targeted the CR6261 epitope on the HA stem of the virus. The authors singled out a compound that demonstrated a promising ability to bind with a broad spectrum of influenza types and further optimized its chemistry to create JNJ4796 - a bioavailable small molecule 'antibody mimetic' that replicates bnAb functionality. According to the results of in vivo evaluation, oral administration of the compound protected mice from extremely lethal doses of H1N1 influenza - more than 25 times the median lethal dose - and greatly increased their survivability during continued exposure. Furthermore, the molecule neutralized viral infection in human bronchial epithelial cells.
-end-


American Association for the Advancement of Science

Related Influenza Articles:

How proteins help influenza A bind and slice its way to cells
Researchers have provided new insight on how two proteins help influenza A virus particles fight their way to human cells.
Eating elderberries can help minimize influenza symptoms
Conducted by Professor Fariba Deghani, Dr. Golnoosh Torabian and Dr.
Mechanism to form influenza A virus discovered
A new study by Maria João Amorim's team, from the Gulbenkian Institute of Science, now reveals where the genomes of the influenza A virus are assembled inside infected cells.
Bat influenza viruses could infect humans
Bats don't only carry the deadly Ebola virus, but are also a reservoir for a new type of influenza virus.
New VaxArray publication on influenza neuraminidase quantification
InDevR Inc. announced publication of 'A Neuraminidase Potency Assay for Quantitative Assessment of Neuraminidase in Influenza Vaccines' in npj Vaccines.
More Influenza News and Influenza Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...